The Indegene Settlement Pays Up to $250 for One Parkinson’s Study Fax Sent February 7, 2020 — Only 18,869 Fax Numbers Qualify, Claims Are Due December 9, 2026, and Every Unclaimed Dollar Stays With Indegene

As of October 11, 2026, the Indegene settlement is open for claims, and the deadline is December 9, 2026 — postmarked or submitted by that date. It covers one fax. The official site defines the class as everyone who was “successfully sent a Fax, on or about February 7, 2020, that states ‘Medical Record Review of the Impact of Adverse Events Associated with the Use of Current anti-Parkinson’s Disease Medications on Patient Clinical Therapeutics and Outcomes Trajectories in the U.S,’ and offers an honorarium of $250 per eligible patient.” According to the complaint, the fax was headed “To: ALL NEUROLOGIST treating Parkinson’s Disease Patients,” so the people who received it are mostly medical practices, not consumers.

The two $250 figures are a coincidence worth keeping apart. The fax offered doctors $250 per eligible patient for a study; the settlement pays up to $250 per valid claim. The settlement agreement says the plaintiff “has determined that the Settlement Class includes the owners of fax numbers that were successfully sent approximately 18,869 alleged advertising faxes,” and only “those Class Members who are in the list of 18,869 fax numbers” can be paid. If you never received this particular fax at a number on that list, this settlement has nothing for you, no matter how many other faxes you got.

The fund is $4,717,250 — by our arithmetic exactly $250 times 18,869, the number of faxes on the list. But it is not all for claimants. The FAQ says class counsel, Anderson + Wanca, will ask for fees and costs of “thirty-five percent of the Settlement Fund for their legal services ($1,651,037.50)” plus an incentive award of $15,000 to the plaintiff, Progressive Health and Rehab Corp., an Ohio corporation, and administration costs also come out of the fund. The payment rule, in the FAQ’s words: claimants “will receive a settlement payment of up to $250. If the total validated claims after payment of attorney’s fees, expenses, and incentive payment of $15,000.00 would exceed the amount of the Settlement Fund, validated claimants will receive a pro rata share.”

Our arithmetic, before administration costs: after the requested fees and the incentive award, about $3,051,212.50 remains, enough to pay the full $250 on roughly 12,204 claims. The number of claims filed has not been published as of October 11, 2026, so the final amount is not known. Only if every one of the 18,869 numbers claimed would the share drop to about $161.70. The agreement also allows “only one claim per fax number.”

Nothing is paid before the court gives final approval at the hearing on January 12, 2027. The agreement then waits for the “Effective Date” — one day after final approval, or, if anyone objected, after appeals run out — and Indegene funds the payments “within 15 (fifteen) business days of the Effective Date.” Payment is a mailed check. Cash it promptly: checks “will be void 120 days after issuance.”

The claim form has three steps: your contact details and every fax number you are claiming for; a signed statement, under penalty of perjury, that “the fax number(s) identified above … was/were mine or my company’s during February, 2020” (there is a second box if you got the number later, with a line to explain when); and returning it by December 9, 2026. You can file online through the official site, fax the form to 952-997-0136, or mail it to Progressive v Indegene, c/o Analytics Consulting LLC, PO Box 2007, Chanhassen, MN 55317-2007. A practice that moved, merged or changed owners since 2020 should look closely at who owned the number in February 2020.

The other options share the same date. To opt out, send a signed written request — full name, address and telephone number, and a sentence such as “Exclude me from the Progressive v. Indegene settlement” — postmarked by December 9, 2026 to class counsel, Anderson + Wanca, 3701 Algonquin Road, Ste 500, Rolling Meadows, IL 60008, with a copy to Indegene’s attorneys at Hinshaw & Culbertson LLP in Chicago. Objections go to the Clerk of the District of New Jersey in Camden, postmarked by the same date, and the site says an objector “must also appear at the final approval hearing January 12, 2027, at 10:00 a.m.” in Room 4D of the Mitchell H. Cohen Building. If you do nothing, you are bound, your claims over the February 2020 fax are released, and “you will receive no payment.”

Because unclaimed money goes back to Indegene, not filing does not leave more for anyone else in the class. The agreement says Indegene “is not required to place all or any portion of the Settlement Fund into a separate bank account” and keeps whatever is not paid out; uncashed checks and other unclaimed amounts “shall revert to and remain the sole property of Defendant, and shall not be paid as a cy pres award or to any third party.”

Yes, if it matches the court-approved plan. The settlement notice is supposed to arrive the same way the original ad did: the agreement says notice goes out “via facsimile”, by first-class mail if the fax fails, and “approximately 21 days after the initial Notice by fax” a second fax goes to everyone on the list who has not responded. The notice says your fax number “was identified in discovery as having been sent a fax.”

The checks you can make: the only official website is IndegeneTCPASettlement.com; the administrator is Analytics Consulting LLC at PO Box 2007, Chanhassen, MN 55317-2007; the claim fax number is 952-997-0136; address changes go to IndegeneTCPASettlement@noticeadministrator.com; class counsel answers at 1-855-827-2329. The claim form asks for name, company, address, phone, email, fax numbers and a signature — it does not ask for a bank account, card number or Social Security number, and nobody needs to pay a fee to file. A message that asks for those, or points you to a different site, is not from this settlement.

The plaintiff sued on August 6, 2020 under the Telephone Consumer Protection Act, alleging that Indegene sent fax advertisements “without express invitation or permission.” Indegene’s position, as the official site records it: the defendants “deny Plaintiff’s allegations, deny any wrongdoing occurred, and raised defenses.” The court certified the class on July 17, 2025; the agreement says the deal was reached with a mediator after discovery, a contested certification fight and a Rule 23 petition by Indegene for an early appeal. The law sets statutory damages of $500 per unlawful fax, which the complaint asked the court to triple. A settlement capped at $250 trades half of that minimum for certainty and no trial.

What type of company is Indegene? The complaint alleged that the defendants are privately held, for-profit “healthcare solutions compan[ies]” that “conduct surveys on behalf of its clients to gather data for their clients’ marketing, sales, and research needs” — the basis for calling a study invitation an advertisement. Indegene, Inc. is a Delaware corporation with its principal place of business in Princeton, New Jersey; the agreement says two of the other named entities have since merged into it and the third was dissolved.

Questions about who runs Indegene, whether it is profitable or what it is like to work there are not part of this case, and the court papers do not answer them; the company’s own corporate and investor disclosures are the place to look. This page is only about the February 2020 fax and the money attached to it. For other open claims, see our list of open class action settlements.